SCHEMBL7425339

SCHEMBL7425339

CCOP(=O)(CCC(=O)NCCc1ccncc1)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
EPHX2 P34913 1/20 0.47
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HPGD P15428 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
NCOR2 Q9Y618 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA5A P35218 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30515391 0.79 HPGD (0.67) SMN1; SMN2RAB9ANPC1EPHX2HDAC2
SCHEMBL2955651 0.79 PPARD (0.42) SMN1; SMN2RAB9ANPC1ALDH1A1NAMPT
SCHEMBL9602529 0.76 HRH1 (0.41) SMN1; SMN2
SCHEMBL12313360 0.76 SMN1; SMN2 (0.58) SMN1; SMN2RAB9ANPC1EPHX2HDAC2
SCHEMBL7423549 0.75 EPHX2 (0.53) SMN1; SMN2RAB9ANPC1EPHX2HDAC2
SCHEMBL27447850 0.74 EPHX2 (0.58) SMN1; SMN2RAB9ANPC1EPHX2HDAC2
SCHEMBL8918862 0.74 NAAA (0.56) SMN1; SMN2RAB9ANPC1EPHX2HDAC2
SCHEMBL2189223 0.74 HSD17B10 (0.63) SMN1; SMN2RAB9ANPC1EPHX2HDAC2
SCHEMBL20543214 0.74 HSD17B10 (0.63) SMN1; SMN2RAB9ANPC1EPHX2HDAC2
SCHEMBL16363845 0.73 HDAC3 (0.57) HDAC2HDAC8HDAC6HPGDHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815103-A1 TRYPSIN AND THROMBIN INHIBITORS Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996029327-A1 TRYPSIN AND THROMBIN INHIBITORS NOVARTIS AG (CH) 1996-09-26 WO disclosed